{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T05:50:17Z","timestamp":1775541017564,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.gore.2025.101715","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T16:57:08Z","timestamp":1741712228000},"page":"101715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Oncologic and fertility outcome in patients with advanced stage ovarian immature teratomas"],"prefix":"10.1016","volume":"58","author":[{"given":"Giuseppe","family":"Marino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Negri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Testa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"De Ponti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Bombelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Pecis Cavagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Lugotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Jaconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Casiraghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina","family":"Bonazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Fruscio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2025.101715_b0005","doi-asserted-by":"crossref","unstructured":"H.O. Smith, M. Berwick, C.F. Verschraegen, C. Wiggins, L. Lansing, C.Y. Muller, C.R. Qualls, Incidence and survival rates for female malignant germ cell tumors., Obstet Gynecol (n.d.). Doi: 10.1097\/01.AOG.0000216004.22588.ce.","DOI":"10.1097\/01.AOG.0000216004.22588.ce"},{"key":"10.1016\/j.gore.2025.101715_b0010","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.ejca.2011.08.008","article-title":"Rare cancers are not so rare: The rare cancer burden in Europe","volume":"47","author":"Gatta","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.gore.2025.101715_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"FIGO Committee on Gynecologic Oncology, Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.gore.2025.101715_b0020","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.ejca.2014.03.288","article-title":"Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978\u20132010)","volume":"50","author":"Solheim","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.gore.2025.101715_b0025","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdy001","article-title":"Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Ray-Coquard","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.gore.2025.101715_b0030","doi-asserted-by":"crossref","first-page":"896","DOI":"10.6004\/jnccn.2019.0039","article-title":"NCCN, Guidelines Insights: Ovarian Cancer, Version 1.2019","volume":"17","author":"Armstrong","year":"2019","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.gore.2025.101715_b0035","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1016\/S1470-2045(20)30091-7","article-title":"ESGO\u2013SIOPE guidelines for the management of adolescents and young adults with non-epithelial ovarian cancers","volume":"21","author":"Sessa","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.gore.2025.101715_b0040","unstructured":"R.J. Kurman, M. Luisa Carcangiu, C. Simon Herrington, R.H. Young, WHO Classification of Tumours of Female Reproductive Organs, (n.d.). https:\/\/www.iarc.who.int\/news-events\/iarc-publications-who-classification-of-tumours-of-female-reproductive-organs-fourth-edition\/."},{"key":"10.1016\/j.gore.2025.101715_b0045","doi-asserted-by":"crossref","unstructured":"H.J. Norris, H.J. Zirkin, W.L. Benson, Immature (malignant) teratoma of the ovary. A clinical and pathologic study of 58 cases, Cancer 37 (1976) 2359\u20132372. Doi: 10.1002\/1097-0142(197605)37:5<2359::AID-CNCR2820370528>3.0.CO;2-Q.","DOI":"10.1002\/1097-0142(197605)37:5<2359::AID-CNCR2820370528>3.0.CO;2-Q"},{"key":"10.1016\/j.gore.2025.101715_b0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jso.21079","article-title":"The influence of conservative surgical practices for malignant ovarian germ cell tumors: Ovarian Germ Cell Tumors","volume":"98","author":"Chan","year":"2008","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.gore.2025.101715_b0060","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1097\/IGC.0b013e3182236582","article-title":"Outcome and Risk Factors for Recurrence in Malignant Ovarian Germ Cell Tumors: A MITO-9 Retrospective Study","volume":"21","author":"Mangili","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gore.2025.101715_b0065","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1200\/JCO.2001.19.4.1015","article-title":"Survival and Reproductive Function After Treatment of Malignant Germ Cell Ovarian Tumors","volume":"19","author":"Zanetta","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gore.2025.101715_b0070","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.7150\/jca.26674","article-title":"Fertility Sparing Management in Non-Epithelial Ovarian Cancer. Which Patients, What Procedure and What Outcome?","author":"Thomakos","year":"2018","journal-title":"J. Cancer 9"},{"key":"10.1016\/j.gore.2025.101715_b0075","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1097\/IGC.0000000000000223","article-title":"Gynecologic Cancer Intergroup (GCIG) Consensus Review for Ovarian Germ Cell Tumors","volume":"24","author":"Brown","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gore.2025.101715_b0080","first-page":"598","article-title":"Pure ovarian immature teratoma, a unique and curable disease: 10 years\u2019 experience of 32 prospectively treated patients","volume":"84","author":"Bonazzi","year":"1994","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.gore.2025.101715_b0085","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejca.2021.05.002","article-title":"Response to letter entitled: Re: Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis","volume":"152","author":"Bergamini","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.gore.2025.101715_b0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ygyno.2013.10.009","article-title":"Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary","volume":"132","author":"Talukdar","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101715_b0095","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ijgc-2018-000013","article-title":"Prognostic significance of residual disease in advanced stage malignant ovarian germ cell tumors","volume":"29","author":"Nasioudis","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gore.2025.101715_b0100","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/ijgc-00009577-200107000-00008","article-title":"Germ cell tumors of the ovary: Is there a role for aggressive cytoreductive surgery for nondysgerminomatous tumors?","volume":"11","author":"Bafna","year":"2001","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gore.2025.101715_b0105","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2007.10.8738","article-title":"Management of Ovarian Germ Cell Tumors","volume":"25","author":"Gershenson","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gore.2025.101715_b0110","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejca.2020.06.033","article-title":"Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis","volume":"137","author":"Bergamini","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.gore.2025.101715_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1330481","article-title":"Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy","volume":"14","author":"Marino","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.gore.2025.101715_b0120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/00016340500334802","article-title":"Does laparoscopic removal of nonendometriotic benign ovarian cysts affect ovarian reserve?","volume":"85","author":"Somigliana","year":"2006","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.gore.2025.101715_b0125","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1200\/JCO.2006.06.5888","article-title":"American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients","volume":"24","author":"Lee","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gore.2025.101715_b0130","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/09513590.2014.907262","article-title":"Menstrual function and childbearing potential after fertility-sparing surgery and platinum-based chemotherapy for malignant ovarian germ cell tumours","volume":"30","author":"Gadducci","year":"2014","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.gore.2025.101715_b0135","first-page":"853","article-title":"Pregnancy following conservative surgery and adjunctive chemotherapy for stage III immature teratoma of the ovary","volume":"73","author":"Lee","year":"1989","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.gore.2025.101715_b0140","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11684-017-0554-3","article-title":"Possibility of women treated with fertility-sparing surgery for non-epithelial ovarian tumors to safely and successfully become pregnant\u2014a Chinese retrospective cohort study among 148 cases","volume":"12","author":"Yang","year":"2018","journal-title":"Front. Med."},{"issue":"385","key":"10.1016\/j.gore.2025.101715_b0145","first-page":"e1","article-title":"Reproductive outcomes of 105 malignant ovarian germ cell tumor survivors: a multicenter study","volume":"219","author":"Tamauchi","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.gore.2025.101715_b0150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ygyno.2023.11.023","article-title":"Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs","volume":"181","author":"Vasta","year":"2024","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101715_b0155","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1136\/ijgc-2024-005534","article-title":"Fertility outcomes in stage I ovarian immature teratomas","volume":"34","author":"Marino","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gore.2025.101715_b0160","first-page":"251","article-title":"Reproductive function after conservative surgery and chemotherapy for malignant germ celltumors of the ovary","volume":"101","author":"Tangir","year":"2003","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.gore.2025.101715_b0165","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ygyno.2017.03.023","article-title":"Analysis of outcomes and prognostic factors after fertility-sparing surgery in malignant ovarian germ cell tumors","volume":"145","author":"Park","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101715_b0170","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ygyno.2017.10.010","article-title":"Fertility-preserving surgery for advanced stage ovarian germ cell tumors","volume":"147","author":"Nasioudis","year":"2017","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578925000402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578925000402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T23:04:09Z","timestamp":1744844649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578925000402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":33,"alternative-id":["S2352578925000402"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2025.101715","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncologic and fertility outcome in patients with advanced stage ovarian immature teratomas","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2025.101715","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101715"}}